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Improving Model Validation in Health Technology Assessment:
Practices Task ForceIn 2012, a joint task force from ISPOR and SMDM produced a set
of guidelines on modeling good practices for research [1].
These articles are highly inﬂuential in the ﬁeld of health
technology assessment, and rightly so. Therefore, we would
like to discuss some concerns they raise about the deﬁnition
and interpretation of an important aspect, namely, model
validation [2].Deﬁnition
The task force deﬁned validation as “a set of methods for judging
a model’s accuracy in making relevant predictions.” This use of
the term “accuracy” goes back to deﬁnitions for the ﬁelds of
engineering and computer sciences, where validation has a long
tradition [3–5]. Crucially, the level of accuracy required in engi-
neering models can be deﬁned a priori and determined a poster-
iori. A benchmark usually exists (a drainage system, a dam, a
motor) to which one can compare the outcomes. Health-economic
decision models, in contrast, facilitate estimation of the conse-
quences of health care decisions, using outcomes that do not lend
themselves to benchmarking. Moreover, in models without
human components, the dynamic behavior to be modeled follows
laws of nature [6], and so they do not need to account for
uncertainty. Models in health economics do, however.
This difference prompted us to adapt the deﬁnition of model
validation for use in the health care setting by avoiding the term
accuracy, reﬂecting the uncertainties intrinsic to our work. In line
with the literature in other ﬁelds [6–8], validation could be
deﬁned as the act of evaluating whether a model is a proper
and sufﬁcient representation of the system it is intended to
represent in view of an application. Here, “proper” means that
the model is in accordance with what is known about the system
and “sufﬁcient” means that the results can serve as a solid basis
for decision making.The Validation Process
The task force distinguishes models to be used once (single-
application) from those to be used several times (multiapplica-
tion). The task force states that validation should be ongoing for a
multiapplication model, while it can be conducted once for a
single-application model [2]. In our opinion, however, validation
should be continuous [5,9], regardless of the number of times a
model is applied. Unfortunately, this recommendation is seldom
followed [4].ial support: This publication is part of a study fund
onMw project number 80-82500-98-12211).Conducting validation throughout the modeling process
would be worth every effort because mistakes could then be
found and corrected at an earlier stage. Validating once toward
the end leaves little time to remedy any problems they
produce. Furthermore, the likelihood of ﬁnding mistakes
increases with the number of validation rounds, minimizing
the chance that the model will contain serious errors when
decisions are made on its basis. In addition, when stake-
holders are continuously involved in building the model,
instead of being asked for comments afterwards, they will be
more inclined to accept it, because they understand its ratio-
nale. Altogether, more validation points could make model
development shorter and cheaper.
While differentiating types of models for validation purposes is
useful, the focus should lie on the outcomes and the decisions to
be based on them, rather than on the number of times the model
will be used. For example, veriﬁcation examines the extent to
which the mathematical calculations are performed correctly and
are consistent with the model’s speciﬁcations [2]. One of the most
powerful veriﬁcation tools is double coding, whereby some or all
the code is programmed twice and independently. Although very
time consuming, this yields a very high level of veriﬁcation. Yet it
is unlikely that the amount of time, effort, and money needed for
double coding will be invested in a model with a relatively small
impact, even if it is used more than once. Nonetheless, double
coding may be cost-effective and perhaps even necessary for
models supporting decisions with large budget impacts.When Is a Model Valid Enough?
According to the authors of the guidelines, “it is not possible to
specify criteria that a model must meet to be declared ‘valid.’ ”
This is true, though we would add that it is possible to
operationalize a level of validity: a model can be “valid
enough” to reliably support a decision to be based on its
outcomes. In this respect, corroboration is a relevant term
[10]. Passing any validation test corroborates the model and
increases its credibility. One of the aims of a project we have
just started is to operationalize validation guidelines by
selecting tools on the grounds of their relevance. We would
then add workable criteria, keeping in mind the impact of the
decisions ultimately to be made on health care and budgets. A
work in progress, we expect it to improve the model review
process by providing an overview of validation tools applied
during its development and their results in relation to the
model’s aim.ed by ZonMw, The Netherlands Organization for Health Research
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We have proposed an alternative deﬁnition of validation because
we felt that the deﬁnition proposed by the task force is not
adequate for health-economic decision models. Any comments
on our proposal are welcome. We have also recommended
introducing validation as a continuous process in all types of
models, thereby dropping the distinction between single-purpose
and multiuse models. Finally, while agreeing with the task force
that it may not be possible to declare a model “valid,” we have
added that it might be possible to call a model “valid enough” for
its purpose. Introducing a continuum of validity is practically
useful and should not be disregarded.
The ISPOR/SMDM Modeling Good Research Practices Task
Force has assembled a state-of-the-art overview of health-
economic decision modeling and has been rightly commended
for this work. Any state of the art, however, is a moving target.
Experience in other scientiﬁc ﬁelds is worth taking into account
to help move the target in health-economic decision modeling,
toward providing reliable support for the important policy deci-
sions facing health care systems today.
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